✦ LIBER ✦

Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United States

✍ Scribed by Andrea M. Abbott; Elizabeth B. Habermann; Todd M. Tuttle

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 183 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25927

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND:

In 2002, the US Food and Drug Administration approved an implantable balloon catheter that delivers accelerated partial breast irradiation (APBI) after breast-conserving surgery (BCS). The objective of the current study was to determine the use of implantable APBI (IAPBI) in the United States and factors associated with IAPBI use. METHODS: By using the Surveillance, Epidemiology, and End Results database, the authors conducted a retrospective analysis of patients who received whole-breast radiotherapy (WBRT) or IAPBI after BCS for ductal carcinoma in situ, AJCC stage I, or stage II breast cancer from 2000 to 2007. WBRT and IAPBI rates were determined across time and demographic and tumor factors using chi-square tests and Cochran-Armitage tests for trend for the unadjusted analyses. RESULTS: A total of 127,257 patients who met inclusion criteria were identified. Over the study period, the proportion of patients receiving IAPBI increased by 1600% (from 0.4% in 2000 to 6.8% in 2007; P <.001). This trend remained significant when using logistic regression (odds ratio, 20.3; 95% confidence interval, 15.5-26.6). The increase in IAPBI use was statistically significant across all stage and age categories >40 years (P <.001). The use of IAPBI was most notable in older women (ages 70-79 years), with a >2100% increase in use noted during the study period (0.4% in 2000 vs 9.0% in 2007; P <.001). The authors also found significant variation in IAPBI use by region. CONCLUSIONS: IAPBI use has markedly increased since 2000, particularly in the elderly population. The rapid and widespread adoption of IAPBI is concerning, because large multicenter randomized controlled trials have not yet demonstrated the long-term effectiveness of IAPBI compared with WBRT.

📜 SIMILAR VOLUMES

Irradiation of the tumor bed alone after

Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy

✍ Vicini, Frank; Kini, Vijay R.; Chen, Peter; Horwitz, Eric; Gustafson, Gary; Beni 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Backgrounds and Objectives: We present the interim findings of our in-house protocol treating the tumor bed alone after lumpectomy with low-dose-rate (LDR) interstitial brachytherapy in selected patients with early-stage breast cancer treated with breast conserving therapy (BCT). Methods: From

Breast conservation therapy in the Unite

Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma

✍ DeAnn Lazovich; Cam C. Solomon; David B. Thomas; Roger E. Moe; Emily White 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

of Health (NIH) Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma, held in June 1990, recommended breast conservation therapy for the majority of women with Stage I or II breast carcinoma. The authors evaluated the national use of breast conserv

The use of molecular assays to establish

The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy

✍ Frank A. Vicini; J. Vito Antonucci; Neal Goldstein; Michelle Wallace; Larry Kest 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract ## BACKGROUND. Results from numerous trials have indicated that breast‐conserving therapy (BCT) produces outcomes equivalent to those produced by mastectomy in terms of both locoregional control and survival. However, conservative treatment has resulted in the dilemma of how best to ad